DiaMedica Therapeutics Inc. Accounts Payable
DiaMedica Therapeutics Inc. (DMAC) had Accounts Payable of $2.81 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable, Current $2.81M.
- 2026-03-31: Accounts Payable, Current $3.29M.
- 2025-12-31: Accounts Payable, Current $1.48M.
- 2025-09-30: Accounts Payable, Current $1.92M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $2.81M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $3.29M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.48M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $1.92M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.26M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.51M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $940.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.17M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $759.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $716.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $926.00K 10-K · filed 2025-03-17 |
| 2023-09-30 | $863.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $856.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.78M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $734.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $864.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $624.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $433.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | $509.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $699.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $239.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $689.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $1.10M 10-K · filed 2022-03-14 |
| 2020-09-30 | $720.00K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $552.00K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $444.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $182.00K 10-K · filed 2021-03-10 |
| 2019-09-30 | $312.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $262.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $685.00K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $483.00K 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |